超音波ニードルガイドの世界市場：2025年～2033年

世界の超音波ニードルガイドの市場規模は、2024年に3億7,253万米ドルとなりました。同市場は、2033年には8億6,631万米ドルに達すると予測され、予測期間の2025年～2033年に8.8％のCAGRで拡大する見込みです。

超音波ニードルガイドは、超音波ガイド下手技で使用される器具であり、針を超音波ビームに整列させ、超音波の視野内に確実に収まるようにします。これにより、針の可視化が改善され、処置時間が短縮され、介入精度が向上し、安全で効率的な針穿刺が容易になります。

世界の超音波ニードルガイド市場は、イメージング、人工知能（AI）、デバイス設計の技術進歩により成長しています。画質と浸透深度が向上した高解像度超音波システムは、正確な針誘導と可視化を可能にします。エラストグラフィやドップラーイメージングのような高度な機能は診断能力を高め、超音波ガイド下手技をより多用途で効果的なものにします。超音波診断装置のAIと機械学習は、リアルタイムの画像解析、針の軌道予測、患者の解剖学に基づく自動調整を支援することで効率を向上させます。

例えば、2024年9月、RIVANNAは先進的な超音波ガイド下針挿入システムの特許を取得し、針を使用した医療処置の精度と安全性の大幅な向上を目指しています。

超音波システムおよびニードルガイドアクセサリーは高価であり、特に低・中所得国では医療インフラや予算が限られていることが多く、普及が妨げられ、高度な超音波ガイド下介入へのアクセスに格差が生じています。

当レポートでは、世界の超音波ニードルガイド市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第4章 戦略的洞察と業界展望

• 市場のリーダーとパイオニア
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第5章 製品タイプ別

• ディスポーザブルニードルガイド
• 再利用型ニードルガイド

第6章 用途別

• 組織生検
• 液体吸引
• 血管アクセス手術
• 神経ブロックと局所麻酔
• その他

第7章 エンドユーザー別

• 病院と診療所
• 外来手術センター
• 診断画像センター
• その他

第8章 地域市場分析と成長機会

• 北米
  • 地域特有の主要な動向
    • 米国
    • カナダ
    • メキシコ
• 欧州
  • 地域特有の主要な動向
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
• 南米
  • 地域特有の主要な動向
    • ブラジル
    • アルゼンチン
    • その他
• アジア太平洋
  • 地域特有の主要な動向
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
• 中東・アフリカ
  • 地域特有の主要な動向

第9章 競合情勢と市場ポジショニング

• 競合状況の概要と主要市場参入企業
• 市場シェア分析とポジショニングマトリックス
• 戦略的パートナーシップ、合併・買収
• 製品ポートフォリオとイノベーションにおける主な発展
• 企業ベンチマーク

第10章 企業プロファイル

• CIVCO Medical Solutions
• 会社概要
• 製品ポートフォリオ
• 財務概要
• 主な発展
• SWOT分析
• GE Healthcare
• Aspen Surgical Products, Inc
• FUJIFILM Sonosite, Inc
• Becton, Dickinson, and Company（BD）
• Argon Medical Devices
• Remington Medical Inc
• GEOTEK Medical
• Rocket Medical
• BIRR

第11章 仮定と調査手法

第12章 付録

The global ultrasound needle guides market reached US$ 372.53 million in 2024 and is expected to reach US$ 866.31 million by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.

Ultrasound needle guides are instruments used in ultrasound-guided procedures to align a needle with the ultrasound beam, ensuring it is within the ultrasound's field of view. This improves needle visualization, reduces procedure time, and enhances intervention accuracy, facilitating safe and efficient needle puncture.

Market Dynamics: Drivers & Restraints

Rise in Technological Advancements

The global ultrasound needle guides market is growing due to technological advancements in imaging, artificial intelligence (AI), and device design. High-resolution ultrasound systems with improved image quality and penetration depth enable precise needle guidance and visualization. Advanced features like elastography and Doppler imaging enhance diagnostic capabilities, making ultrasound-guided procedures more versatile and effective. AI and machine learning in ultrasound devices improve efficiency by assisting with real-time image analysis, needle trajectory prediction, and automatic adjustments based on patient anatomy.

For instance, in September 2024, RIVANNA secured a patent for an advanced ultrasound-guided needle insertion system, aiming to significantly improve the accuracy and safety of needle-based medical procedures.

High Cost and Limited Accessibility in Low-Income Regions

Ultrasound systems and needle guide accessories are expensive, especially in low- and middle-income countries, which often face limited healthcare infrastructure and budget constraints, hindering widespread adoption and creating disparities in access to advanced ultrasound-guided interventions.

Segment Analysis

The global ultrasound needle guides market is segmented based on product type, application, end-user, and region.

Product Type:

The disposable needle guides from the product type segment is expected to dominate the ultrasound needle guides market with the highest market share.

Disposable needle guides are medical accessories made from medical-grade plastic, pre-sterilized to ensure safety and minimize cross-contamination. They assist in precise needle direction during ultrasound-guided procedures, aligning the needle path with the ultrasound beam, improving accuracy, and reducing procedural errors.

The disposable needle guides market is being driven by product launches, increasing focus on infection control and hospital-acquired infection prevention. Regulatory bodies and healthcare institutions are promoting single-use devices to reduce sterilization costs and comply with safety standards. The convenience and time efficiency of disposable guides, coupled with increasing procedure volumes, are driving market demand.

Geographical Analysis

North America is expected to hold a significant position in the ultrasound needle guides market, with the highest market share

The ultrasound needle guides market in North America is fueled by advanced healthcare infrastructure, high imaging technology adoption, and minimally invasive procedures. The region benefits from significant healthcare investments, skilled professionals, and supportive reimbursement policies. The rising prevalence of chronic diseases like cancer and cardiovascular conditions, which often require image-guided biopsies or catheter placements, further increases the demand for needle guides in clinical settings.

For instance, in November 2023, DeepSight Technology introduced its ultrasound-guided needle technology, NeedleVue, which offers safety in directed interventional tool guidance. It combines advanced sensor technology with interventional devices, enabling real-time placement verification and reducing procedural guesswork.

Competitive Landscape

The major global players in the ultrasound needle guides market include CIVCO Medical Solutions, GE Healthcare, Aspen Surgical Products, Inc., FUJIFILM Sonosite, Inc., Becton, Dickinson and Company (BD), Argon Medical Devices, Remington Medical Inc., GEOTEK Medical, Rocket Medical, and BIRR, among others.

Key Developments

• In July 2024, Intelligent Ultrasound (IU) launched NeedleTrainer 2.6, a new training solution for ultrasound-guided needling. The all-in-one training tool offers improved applicability across various needling practices and a new mode and e-learning for common vascular access procedures. It uses non-invasive needle insertion during real-time scanning on a real subject.

Why Purchase the Report?

• Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-world Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ultrasound needle guides market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Product Type
• 2.4. Snippet by Application
• 2.5. Snippet by End User
• 2.6. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rise in the Technological Advancements
    • 3.1.1.2. Rising Adoption of Minimally Invasive Procedures
  • 3.1.2. Restraints
    • 3.1.2.1. High Cost and Limited Accessibility in Low-Income Regions
    • 3.1.2.2. Regulatory Challenges
  • 3.1.3. Opportunity
    • 3.1.3.1. Integration of AI with Ultrasound for Enhanced Targeting
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest largest-selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East & Africa
• 4.6. Porter's Five Force Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. By Product Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 5.1.2. Market Attractiveness Index, By Product Type
• 5.2. Disposable Needle Guides*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Reusable Needle Guides

6. By Application

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 6.1.2. Market Attractiveness Index, By Application
• 6.2. Tissue Biopsy*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Fluid Aspiration
• 6.4. Vascular Access Procedures
• 6.5. Nerve Block and Regional Anesthesia
• 6.6. Others

7. By End User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 7.1.2. Market Attractiveness Index, By End User
• 7.2. Hospitals and Clinics*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Ambulatory Surgical Centers
• 7.4. Diagnostic Imaging Centers
• 7.5. Others

8. Regional Market Analysis and Growth Opportunities

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 8.1.2. Market Attractiveness Index, By Region
• 8.2. North America
  • 8.2.1. Introduction
  • 8.2.2. Key Region-Specific Dynamics
  • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.2.6.1. U.S.
    • 8.2.6.2. Canada
    • 8.2.6.3. Mexico
• 8.3. Europe
  • 8.3.1. Introduction
  • 8.3.2. Key Region-Specific Dynamics
  • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.3.6.1. Germany
    • 8.3.6.2. U.K.
    • 8.3.6.3. France
    • 8.3.6.4. Spain
    • 8.3.6.5. Italy
    • 8.3.6.6. Rest of Europe
• 8.4. South America
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.4.6.1. Brazil
    • 8.4.6.2. Argentina
    • 8.4.6.3. Rest of Latin America
• 8.5. Asia-Pacific
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 8.5.6.1. China
    • 8.5.6.2. India
    • 8.5.6.3. Japan
    • 8.5.6.4. South Korea
    • 8.5.6.5. Rest of Asia-Pacific
• 8.6. Middle East and Africa
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape and Market Positioning

• 9.1. Competitive Overview and Key Market Players
• 9.2. Market Share Analysis and Positioning Matrix
• 9.3. Strategic Partnerships, Mergers & Acquisitions
• 9.4. Key Developments in Product Portfolios and Innovations
• 9.5. Company Benchmarking

10. Company Profiles

• 10.1. CIVCO Medical Solutions*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. GE Healthcare
• 10.3. Aspen Surgical Products, Inc
• 10.4. FUJIFILM Sonosite, Inc
• 10.5. Becton, Dickinson, and Company (BD)
• 10.6. Argon Medical Devices
• 10.7. Remington Medical Inc
• 10.8. GEOTEK Medical
• 10.9. Rocket Medical
• 10.10. BIRR

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

• 11.1. Data Collection Methods
• 11.2. Data Triangulation
• 11.3. Forecasting Techniques
• 11.4. Data Verification and Validation

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us